FDA Takes Action to Stop Marketing of Unapproved Timed-Release Guaifenesin
FDA Takes Action to Stop Marketing of Unapproved Timed-Release Guaifenesin Drug Products
Approximately 20 firms make timed-release products containing guaifenesin that have not undergone FDA review and as a result are considered by the agency to be unapproved drugs.